4.4 Article

Assessment of bolus transit with intraluminal impedance measurement in patients with esophageal motility disorders

Journal

NEUROGASTROENTEROLOGY AND MOTILITY
Volume 27, Issue 10, Pages 1446-1452

Publisher

WILEY
DOI: 10.1111/nmo.12642

Keywords

bolus transport; dysphagia; esophagus; impedance measurement; stasis; videofluoroscopy

Ask authors/readers for more resources

Background The clinical management of patients with non-obstructive dysphagia is notoriously difficult. Esophageal impedance measurement can be used to measure esophageal bolus transit without the use of radiation exposure to patients. However, validation of measurement of bolus transit with impedance monitoring has only been performed in healthy subjects with normal motility and not in patients with dysphagia and esophageal motility disorders. The aim was, therefore, to investigate the relationship between transit of swallowed liquid boluses in healthy controls and in patients with dysphagia. Methods Twenty healthy volunteers and 20 patients with dysphagia underwent concurrent impedance measurement and videofluoroscopy. Each subject swallowed five liquid barium boluses. The ability of detecting complete or incomplete bolus transit by means of impedance measurement was assessed, using radiographic bolus transit as the gold standard. Key Results Impedance monitoring recognized stasis and transit in 80.5% of the events correctly, with 83.9% of bolus transit being recognized and 77.2% of stasis being recognized correctly. In controls 79.8% of all swallows were scored correctly, whereas in patients 81.3% of all swallows were scored correctly. Depending on the contractility pattern, between 77.0% and 94.3% of the swallows were scored correctly. Conclusions (sic) Inferences Impedance measurement can be used to assess bolus clearance patterns in healthy subjects, but can also be used to reliably assess bolus transit in patients with dysphagia and motility disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Pneumatic dilation for persistent dysphagia after antireflux surgery, a multicentre single-blind randomised sham-controlled clinical trial

Jeroen M. Schuitenmaker, Froukje B. van Hoeij, Marlies P. Schijven, Jan Tack, Jose M. Conchillo, Eric J. Hazebroek, Andre J. P. M. Smout, Albert J. Bredenoord

Summary: The study results indicate that pneumatic dilation with a 35 mm balloon is not superior to sham dilation for the treatment of persistent dysphagia after fundoplication.
Review Gastroenterology & Hepatology

What is new in Chicago Classification version 4.0?

Rena Yadlapati, John E. Pandolfino, Mark R. Fox, Albert J. Bredenoord, Peter J. Kahrilas

Summary: Key modifications in Chicago Classification version 4.0 (CCv4.0) include increased requirements for diagnosis of esophagogastric junction outflow obstruction, stricter criteria for the clinical relevance of manometric patterns, standardization of manometric protocol, redefinition of ineffective esophageal motility, and a shift from distinguishing major versus minor motility disorders to separation of disorders of EGJ outflow from disorders of peristalsis.

NEUROGASTROENTEROLOGY AND MOTILITY (2021)

Article Gastroenterology & Hepatology

Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0(C)

Rena Yadlapati, Peter J. Kahrilas, Mark R. Fox, Albert J. Bredenoord, C. Prakash Gyawali, Sabine Roman, Arash Babaei, Ravinder K. Mittal, Nathalie Rommel, Edoardo Savarino, Daniel Sifrim, Andre Smout, Michael F. Vaezi, Frank Zerbib, Junichi Akiyama, Shobna Bhatia, Serhat Bor, Dustin A. Carlson, Joan W. Chen, Daniel Cisternas, Charles Cock, Enrique Coss-Adame, Nicola de Bortoli, Claudia Defilippi, Ronnie Fass, Uday C. Ghoshal, Sutep Gonlachanvit, Albis Hani, Geoffrey S. Hebbard, Kee Wook Jung, Philip Katz, David A. Katzka, Abraham Khan, Geoffrey Paul Kohn, Adriana Lazarescu, Johannes Lengliner, Sumeet K. Mittal, Taher Omari, Moo In Park, Roberto Penagini, Daniel Pohl, Joel E. Richter, Jordi Serra, Rami Sweis, Jan Tack, Roger P. Tatum, Radu Tutuian, Marcelo F. Vela, Reuben K. Wong, Justin C. Wu, Yinglian Xiao, John E. Pandolfino

Summary: CCv4.0 is an updated classification scheme for esophageal motility disorders using HRM, developed by fifty-two international experts in seven subgroups over two years. Key updates include a more rigorous and expansive HRM protocol, refined definition of EGJOO, stricter criteria for ineffective esophageal motility, and description of baseline EGJ metrics. These changes aim to provide more standardized criteria for disorders of peristalsis and obstruction at the EGJ.

NEUROGASTROENTEROLOGY AND MOTILITY (2021)

Article Gastroenterology & Hepatology

Mental distress among adult patients with eosinophilic esophagitis

Willemijn E. de Rooij, Floor Bennebroek Evertsz', A. Lei, Albert J. Bredenoord

Summary: The research found that some adult EoE patients suffer from mental distress, with patients aged 18-35 at a 3-fold risk of significant anxiety. Population-based studies are needed and a proactive approach in screening for and treating these psychological symptoms in EoE practice is essential.

NEUROGASTROENTEROLOGY AND MOTILITY (2021)

Article Nutrition & Dietetics

The Habitual Diet of Dutch Adult Patients with Eosinophilic Esophagitis Has Pro-Inflammatory Properties and Low Diet Quality Scores

Marlou L. A. de Kroon, Simone R. B. M. Eussen, Bridget A. Holmes, Lucien F. Harthoorn, Marijn J. Warners, Albert J. Bredenoord, Bram D. van Rhijn, Mylene van Doorn, Berber J. Vlieg-Boerstra

Summary: The study found that adult EoE patients had higher saturated fat intake and lower dietary fiber intake. EoE patients had lower overall diet quality compared to the general population.

NUTRIENTS (2021)

Review Immunology

Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies

Elizabeth A. Jacobsen, David J. Jackson, Enrico Heffler, Sameer K. Mathur, Albert J. Bredenoord, Ian D. Pavord, Praveen Akuthota, Florence Roufosse, Marc E. Rothenberg

Summary: Research on manipulating mouse and human eosinophils through experimental systems has made significant progress in revealing their roles in the immune system. Anti-eosinophil therapeutics have emerged as a new class of drugs, offering valuable insights into the consequences of eosinophil knockout in humans.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 39 (2021)

Review Gastroenterology & Hepatology

Long-term outcomes of treatments for achalasia

Sara Nullens, Paul Fockens, Albert J. Bredenoord

Summary: Idiopathic achalasia is a primary motility disorder of the esophagus, leading to symptoms such as dysphagia and weight loss. There are various treatment options, with POEM and LHM showing good success rates for symptom relief, although POEM is associated with a higher risk of reflux disease and erosive esophagitis.

CURRENT OPINION IN GASTROENTEROLOGY (2021)

Review Gastroenterology & Hepatology

Disease Burden and Unmet Need in Eosinophilic Esophagitis

Albert J. Bredenoord, Kiran Patel, Alain M. Schoepfer, Evan S. Dellon, Mirna Chehade, Seema S. Aceves, Jonathan M. Spergel, Brad Shumel, Yamo Deniz, Paul J. Rowe, Juby A. Jacob-Nara

Summary: Eosinophilic esophagitis is a chronic inflammatory disease that has a negative impact on patients' quality of life. Current treatments do not provide long-term disease control, highlighting the need for effective long-term therapies and a better understanding of patients' perspectives.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)

Article Pharmacology & Pharmacy

Eosinophilic esophagitis: New molecules, better life?

Angela Y. Lam, Christopher Ma, Jeffrey K. Lee, Albert J. Bredenoord

Summary: Eosinophilic esophagitis (EoE) is an increasingly common inflammatory disorder causing esophageal symptoms, and there are currently no approved therapies. However, progress in understanding the underlying pathophysiology has led to the development of new molecular targeted treatments that may change the management of EoE in the future.

CURRENT OPINION IN PHARMACOLOGY (2022)

Review Gastroenterology & Hepatology

Systematic review: Clinical effectiveness of interventions for the treatment of nocturnal gastroesophageal reflux

Jeroen M. Schuitenmaker, Thijs Kuipers, Andre J. P. M. Smout, Paul Fockens, Albert J. Bredenoord

Summary: For the treatment of nocturnal gastroesophageal reflux symptoms, a sequential treatment strategy involving head of bed elevation, prolonging dinner-to-bed time, promoting left lateral decubitus position, and acid-suppressive medication is recommended. Insufficient evidence currently exists for the use of nCPAP, hypnotics, baclofen, and adding bedtime H2 receptor antagonists to reduce nocturnal reflux symptoms.

NEUROGASTROENTEROLOGY AND MOTILITY (2022)

Editorial Material Gastroenterology & Hepatology

Eosinophilic esophagitis and the promise of vitamin D

Albert J. Bredenoord

Article Gastroenterology & Hepatology

The effect of sleep positional therapy on nocturnal gastroesophageal reflux measured by esophageal pH-impedance monitoring

Jeroen M. Schuitenmaker, Thijs Kuipers, Marlies P. Schijven, Andre J. P. M. Smout, Paul Fockens, Albert J. Bredenoord

Summary: This study evaluated the effect of an electronic positional therapy wearable device on nocturnal gastroesophageal reflux. The results showed that the device improved reflux symptoms, reduced the number of reflux episodes, and promoted left lateral decubitus sleep position, leading to improvement in reflux parameters.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Gastroenterology & Hepatology

Development and modification of a dysphagia question prompt list to improve patient-physician communication: Incorporating both esophageal expert and patient perspectives

Sudharshan Achalu, Rani Berry, Justin Zhuo, Albert J. Bredenoord, John O. Clarke, Ronnie Fass, C. Prakash Gyawali, Peter J. Kahrilas, David A. Katzka, Benson T. Massey, Roberto Penagini, Sabine Roman, Edoardo Savarino, Marcelo F. Vela, Afrin N. Kamal

Summary: This study aimed to develop a dysphagia-specific question prompt list (QPL) to improve patient-physician communication. A two-round Delphi method and survey were used to generate a QPL consisting of 40 questions, incorporating both expert and patient perspectives.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Gastroenterology & Hepatology

Dupilumab demonstrated efficacy and was well tolerated regardless of prior use of swallowed topical corticosteroids in adolescent and adult patients with eosinophilic oesophagitis: a subgroup analysis of the phase 3 LIBERTY EoE TREET study

Albert J. Bredenoord, Evan Dellon, Ikuo Hirano, Alfredo J. Lucendo, Christoph Schlag, Xian Sun, Lila Glotfelty, Leda Mannent, Jennifer Maloney, Elizabeth Laws, Eric Mortensen, Arsalan Shabbir

Article Gastroenterology & Hepatology

10-year follow-up results of the European Achalasia Trial: a multicentre randomised controlled trial comparing pneumatic dilation with laparoscopic Heller myotomy

Guy Boeckxstaens, Stefanie Elsen, Ann Belmans, Vito Annese, Albert J. Bredenoord, Olivier R. Busch, Mario Costantini, Uberto Fumagalli, Andre J. P. M. Smout, Jan Tack, Tim Vanuytsel, Giovanni Zaninotto, Renato Salvador

Summary: The 10-year follow-up of the European Achalasia Trial comparing endoscopic pneumodilation (PD) with laparoscopic Heller myotomy (LHM) showed that both treatments are equally effective in treating achalasia, with limited risk of developing gastro-oesophageal reflux.
No Data Available